Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vesencumab (MNRP-1685A), an IG1 antibody targeting neuropilin-1 (NRP-1), inhibits the interaction between NRP-1 and VEGFR-2. This action confers anti-angiogenic and anti-neoplastic properties to Vesencumab. It is utilized in studying metastatic solid tumors, notably ovarian cancer [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Vesencumab (MNRP-1685A), an IG1 antibody targeting neuropilin-1 (NRP-1), inhibits the interaction between NRP-1 and VEGFR-2. This action confers anti-angiogenic and anti-neoplastic properties to Vesencumab. It is utilized in studying metastatic solid tumors, notably ovarian cancer [1] [2]. |
Molecular Weight | N/A |
CAS No. | 1205533-60-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vesencumab 1205533-60-3 inhibitor inhibit